Murlentamab

MedChem Express

Murlentamab

10

Research Use Only

95.00

Murlentamab (3C23K; GM102) is a humanized anti-AMHRII antibody. AMHRII is the anti-Muellerian hormone receptor. Murlentama significantly promotes macrophage-mediated antibody-dependent cell-mediated cytotoxicity (ADCC). Murlentama stimulates pro-inflammatory and anti-tumor internal environment, recruits and activates T cells. Murlentama suppresses tumors growth by inducing naive macrophage orientation and promoting tumor-associated macrophage (TAM) reprogramming[1].

-80°C

12352203